iBio, Inc. (NYSE: IBIO) announced the successful application of its proprietary technologies to achieve the first milestone in its commercial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE